Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The annual BIO International conference is large. Very ...

BOSTON, April 6, 2026 /PRNewswire/ -- As artificial intelligence moves from experimentation to execution in life sciences, the 25th Annual Bio-IT World Conference & Expo will spotlight how ...

MIAMI, May 28, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (LGVN) (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and ...

WALTHAM, Mass., April 8, 2026 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata (AA) and ...

Bio-Path Holdings will host a conference call on May 29, 2025, to discuss its business overview and pipeline developments. Bio-Path Holdings, Inc., a biotechnology company focused on developing cancer ...

KELOWNA, BC / ACCESS Newswire / June 5, 2025 / Lexaria Bioscience Corp. (LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that its Chief ...

Live webcast presentation on Wednesday, September 24th at 9:55 AM PT SOUTH SAN FRANCISCO, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a ...